Literature DB >> 9696884

Hormonal control of pituitary prolactin-secreting tumors.

D K Sarkar1, S T Hentges, A De, R H Reddy.   

Abstract

Prolactin secreting adenomas (prolactinomas) are the most prevalent form of pituitary tumors in humans. Prolactinomas have been linked to estrogen exposure in humans and animals. However, the mechanism by which estrogen increases mitogenesis in lactotropes, as well as other estrogen responsive cells, is not well understood. Given the complex nature of steroid hormones and their wide array of actions, it seems plausible that there are multiple ways in which estrogen can exert its cell-transforming actions. Estrogen has a wide range of actions on cells depending on the cell type, receptor levels, and other factors present in the cell. A defect at any point could play a potential role in cell transformation. The source of such defects could be the result of any of a wide range of possibilities, including genetic predisposition, prolonged exposure to sufficient levels of the steroid hormone, or other insults to the cell which lead to altered responsiveness to estrogen in some way. This review discusses the recent advances that have been made in the area of understanding estrogen action in transformation of pituitary lactotropes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696884     DOI: 10.2741/a334

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  15 in total

1.  Isolation and characterization of rat pituitary endothelial cells.

Authors:  Kirti Chaturvedi; Dipak K Sarkar
Journal:  Neuroendocrinology       Date:  2006-10-04       Impact factor: 4.914

2.  Transforming growth factor-beta3 increases gap-junctional communication among folliculostellate cells to release basic fibroblast growth factor.

Authors:  Nurul Kabir; Kirti Chaturvedi; Lian Sheng Liu; Dipak K Sarkar
Journal:  Endocrinology       Date:  2005-06-16       Impact factor: 4.736

3.  Casticin, a flavonoid isolated from Vitex rotundifolia, inhibits prolactin release in vivo and in vitro.

Authors:  Qi YE; Qiao-yan ZHANG; Cheng-jian ZHENG; Yang WANG; Lu-ping QIN
Journal:  Acta Pharmacol Sin       Date:  2010-11-01       Impact factor: 6.150

Review 4.  Genesis of prolactinomas: studies using estrogen-treated animals.

Authors:  Dipak K Sarkar
Journal:  Front Horm Res       Date:  2006       Impact factor: 2.606

5.  Ept7 influences estrogen action in the pituitary gland and body weight of rats.

Authors:  Scott G Kurz; Kirsten L Dennison; Nyssa Becker Samanas; Maureen Peters Hickman; Quincy A Eckert; Tiffany L Walker; Andrea S Cupp; James D Shull
Journal:  Mamm Genome       Date:  2014-01-22       Impact factor: 2.957

6.  Subchronic exposure to phytoestrogens alone and in combination with diethylstilbestrol - pituitary tumor induction in Fischer 344 rats.

Authors:  Yow-Jiun Jeng; Mikhail Kochukov; Dhananjaya Nauduri; Bhupendra S Kaphalia; Cheryl S Watson
Journal:  Nutr Metab (Lond)       Date:  2010-05-10       Impact factor: 4.169

7.  Rat strain specific attenuation of estrogen action in the anterior pituitary gland by dietary energy restriction.

Authors:  Djuana M E Harvell; Linda K Buckles; Karen A Gould; Karen L Pennington; Rodney D McComb; James D Shull
Journal:  Endocrine       Date:  2003-07       Impact factor: 3.633

8.  Tissue-specific actions of the Ept1, Ept2, Ept6, and Ept9 genetic determinants of responsiveness to estrogens in the female rat.

Authors:  Scott G Kurz; Kimberly K Hansen; Mac T McLaughlin; Vijay Shivaswamy; Beverly S Schaffer; Karen A Gould; Rodney D McComb; Jane L Meza; James D Shull
Journal:  Endocrinology       Date:  2008-04-17       Impact factor: 4.736

9.  Ethanol alters production and secretion of estrogen-regulated growth factors that control prolactin-secreting tumors in the pituitary.

Authors:  Dipak K Sarkar; Nadka I Boyadjieva
Journal:  Alcohol Clin Exp Res       Date:  2007-12       Impact factor: 3.455

10.  Proliferative and anti-proliferative effects of dietary levels of phytoestrogens in rat pituitary GH3/B6/F10 cells - the involvement of rapidly activated kinases and caspases.

Authors:  Yow-Jiun Jeng; Cheryl S Watson
Journal:  BMC Cancer       Date:  2009-09-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.